glp 1 agonist drugs mechanism of action Frontiers Recent updates on GLP-1 agonists:

That second pathway explains why prolonged deficiency causes neurological damage and not simply anaemia

Shao L, Wang C, Xu G et al (2024) Utilizing reactive oxygen species-scavenging nanoparticles for targeting oxidative stress in the treatment of ischemic stroke: a review

Hyperglycemia is responsible for the generation of advanced glycation end products (AGEs) that can damage the kidney through receptor (RAGE)-dependent and -independent mechanisms [55]

Absolute no-go: active or recent malignancy

Because it provides a detailed explanation of how the C rating operates and its impact on battery life and performance